Hemorel A Dried Factor VIII 250 IU Injection

Description

Introduction of Hemorel-A 250IU Injection:

Hemorel-A 250IU Injection is a plasma-derived clotting factor medicine used in the treatment of hemophilia A. Its active ingredient is dried Factor VIII fraction I.P. (human coagulation Factor VIII). It is double viral inactivated, which is a process used to reduce the risk of transmitting viruses from the human plasma it is made from.

Hemorel-A 250IU Injection is supplied as a dried (lyophilized) powder and is for intravenous (IV) use only. It must be prepared with the supplied solvent exactly as directed, and it should be given by or under the supervision of a doctor or a trained healthcare professional. The dose and the schedule depend on the severity of the Factor VIII deficiency, the site and extent of the bleeding, and your body weight, and they may change from time to time. Do not change the dose on your own.

Allergic reactions, headache, and fever are among the most common side effects of this medicine. Inform your doctor immediately if you notice a rash, itching, swelling of the face or throat, chest tightness, or difficulty in breathing. Regular monitoring of Factor VIII levels is required during treatment, as some patients may develop inhibitors (antibodies) that reduce the effect of the medicine.

Uses of Hemorel-A 250IU Injection:

• Hemophilia A (congenital Factor VIII deficiency)
• Control and prevention of bleeding episodes in patients with Factor VIII deficiency
• Prevention and control of bleeding during and after surgery in patients with Factor VIII deficiency

Benefits of Hemorel-A 250IU Injection:

1. Hemophilia A

Hemophilia A is an inherited bleeding disorder in which the blood does not clot properly because the body lacks enough Factor VIII, a protein needed for clotting. Hemorel-A 250 IU Injection replaces the missing Factor VIII, which helps the blood to clot and helps stop and prevent bleeding.

2. Control of bleeding episodes

Bleeding into joints, muscles, and soft tissues is common in hemophilia A and can cause pain and long-term damage. Hemorel-A 250 IU Injection raises the level of Factor VIII in the blood, which helps control bleeding quickly and reduces complications.

3. Surgical and dental procedures

Patients with Factor VIII deficiency are at risk of excessive bleeding during surgery and other procedures. Hemorel-A 250 IU Injection helps maintain adequate clotting before, during, and after the procedure.

Side Effects of Hemorel-A 250IU Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you are worried about them.

Common side effects of Hemorel-A 250IU Injection:

• Headache
• Fever
• Chills
• Nausea
• Vomiting
• Skin rash
• Itching
• Dizziness
• Pain or redness at the injection site
• Allergic reactions
• Development of Factor VIII inhibitors

Mechanism of Action of Hemorel-A 250IU Injection:

Hemorel-A 250IU Injection is a blood clotting factor replacement medication. Factor VIII is a protein that works together with Factor IXa to activate Factor X in the clotting process. This leads to the formation of thrombin and then a fibrin clot that stops bleeding. In people with hemophilia A, this protein is missing or low.

Contact Us